Cargando…

Ad26.cov2-s: Diffuse erythematous dermatitis: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990548/ http://dx.doi.org/10.1007/s40278-022-12693-z

Ejemplares similares

Ad26.cov2-s: Myocarditis: case report
Publicado: (2021)

Ad26.cov2-s: Rhabdomyolysis: case report
Publicado: (2021)

Diffuse erythematous rash after teneligliptin therapy: A case report
por: Agrawal, Prabhat, et al.
Publicado: (2018)

Ad26.cov2-s: Thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Bell's palsy: case report
Publicado: (2022)

Ad26.COV2-S: Transient thrombocytopenia: case report
Publicado: (2022)

Ad26.COV2-S: Thrombocythemia-thrombotic: case report
Publicado: (2022)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Ad26.COV2-S: Multisystem inflammatory syndrome: case report
Publicado: (2022)

Ad26.COV2-S: Cerebral venous thrombosis: case report
Publicado: (2022)

Ad26.cov2-s: Inflammatory heart disease: case report
Publicado: (2022)

Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: case report
Publicado: (2022)

Ad26.cov2-s: Thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Ad26.COV2-S: Immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2 S: Guillian Barre syndrome: case report
Publicado: (2022)

Ad26.COV2-S: Cerebral venous thrombosis: case report
Publicado: (2022)

Ad26.cov2-s: Immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.cov2-s: Immune-thrombotic thrombocytopenia: case report
Publicado: (2022)

Ad26.COV2-S: Guillain-Barre syndrome: case report
Publicado: (2021)

Ad26.COV2-S: Deep venous thrombosis: case report
Publicado: (2021)

Ad26.cov2-s: Portal vein thrombosis: case report
Publicado: (2021)

Ad26.COV2-S/elasomeran/tozinameran: Myocarditis: 7 case reports
Publicado: (2022)

Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: 3 case reports
Publicado: (2021)

Ad26.CoV2-S/heparin: Various toxicities: case report
Publicado: (2021)

Allergic Contact Dermatitis with Diffuse Erythematous Reaction from Diisopropanolamine in a Compress
por: Rind, Tomoko, et al.
Publicado: (2010)

Ad26.COV2-S/AZD-1222: Thrombotic thrombocytopenia: 5 case reports
Publicado: (2022)

Ad26.cov2-s: Guillain Barre syndrome and fulminant encephalomyelitis: case report
Publicado: (2022)

Ad26.cov2-s: Fatigue, fever and hypertensive crisis: 3 case reports
Publicado: (2022)

Tozinameran: Erythematous skin rash with blisters : case report
Publicado: (2022)

Ad26.cov2-s/immune-globulin: Guillain barre syndrome and pseudohyponatraemia: case report
Publicado: (2022)

Ad26.cov2-s/elasomeran/tozinameran: Vaccine breakthrough infection: 76 case reports
Publicado: (2022)

Ad26.CoV2-S/elasomeran: Thrombosis with thrombocytopenia syndrome: 6 case reports
Publicado: (2022)

Ad26.cov2-s: Pulmonary embolism, transient ischaemic attack and thrombocytopenia: case report
Publicado: (2021)

Ad26.cov2-s/immune-globulin: Immune mediated thrombocytopenia and no response: case report
Publicado: (2021)

Ad26.COV2-S: Cerebral Venous Sinus Thrombosis with Thrombocytopenia: 14 case reports
Publicado: (2021)

Ad26.COV2-S: Thrombotic thrombocytopenia and cerebral venous sinus thrombosis: case report
Publicado: (2021)

Ad26.COV2-S: Cerebral venous sinus thrombosis and unmasking of inherited thrombophilia: case report
Publicado: (2022)

Erythematous Granuloma Annulare
por: Jang, Eun Joo, et al.
Publicado: (2011)

Ad26.COV2-S/COVID-19-Vaccine-Pfizer-BioNTech: Lack of efficacy: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_djai3rrj8ercv1g0d5f0r091kg